Although the serum levels of hs-CRP, MMP-9 and I-CAM were more elevated in patients that had presented acute phase complications (electrical or hemodynamic), the difference did not reach statistical significance neither for the total number of patients, nor during separate analysis for STEMI and NSTEMI.
← all excerpts
Systemic Vulnerability, as Expressed by I-CAM and MMP-9 at Presentation, Predicts One Year Outcomes in Patients with Acute Myocardial Infarction-Insights from the VIP Clinical Study.
1
—
—